Amgen Inc., AMGN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Amgen Inc., AMGN has a market cap of 121586.9. Since its IPO date on the 9/7/1984, Amgen Inc., AMGN performance year to date is 1.68%. Today Amgen Inc., AMGN has gained -1.45%, with a current price of 161.9.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 81.10%. The management of the company have seen the company have a payout ratio of 36.30%. Return of assets are at 10.10%, with return on investment at 12.50%.
In terms of debt levels and profit levels, Amgen Inc., AMGN is seeing a long-term debt/equity of 0.93. While Total debt/equity is 1.1. With a profit margin of 33.10%, this is combined with a gross margin of 81.40%, and operating margin of 40.70%. Amgen Inc. ability to meet debt levels, with a current ratio of 4, while the quick ratio is 3.7.
For the last year Amgen Inc., AMGN has seen a EPS growth of 35.20%. A performance for the year of 8.75%. The 52-week high is -8.45%, and the 52-week low is 17.91%. The average volume for Amgen Inc., AMGN is 2816519.
With a target price of 189.81, can Amgen Inc., AMGN reach this target? Looking at the value indicators of Amgen Inc., AMGN. Amgen Inc. has a P/E of 16.57 and a forward P/E of 12.96. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.09. Amgen Inc. also has a P/S and a P/B of 5.41 and 4.04 respectively. For P/cash, Amgen Inc. has a value of 3.47, while it is 20.31 for P/free cash flow.
At the current price of 161.9, Amgen Inc. has a dividend yield of 2.47%. We see a return on equity of 25.90%.
Looking more long-term Amgen Inc., is projected to get an EPS growth for the next five years of 7.93%. In the short-term an EPS growth of 10.07% in the next year is forecasted. This is after a EPS growth of 35.20% for this year and for the last five years a 13.60% growth has been seen.